GKC announced today that it has appointed John Schellhorn as its new President and CEO. Schellhorn will also be joining the company’s Board of Directors.
Schellhorn joins GKC with a proven track record to spearhead the company’s accelerated growth strategy to meet the demand for its lead product, the PKG™ system.
With extensive experience in the commercialisation of innovative medical technologies, Schellhorn was President and CEO of Monteris Medical and Chief Commercialization Officer for Barrx Medical. Prior to Barrx, he served as President and CEO of Softscope Medical Technologies and has also built a number of businesses for Boston Scientific in Asia and Australia.
Schellhorn will be US-based as he oversees the company’s increasing focus on the world’s largest health technology market.
Please click here for more information
